Study of Improving Insulin Sensitivity by Electroacupuncture Therapy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00379379|
Recruitment Status : Completed
First Posted : September 21, 2006
Last Update Posted : September 21, 2006
|Condition or disease||Intervention/treatment||Phase|
|Diabetes Mellitus, Type 2 Insulin Resistance||Device: electroacupuncture||Not Applicable|
Some previous animal model studies reveal that electroacupuncture (EA) applying on specific acupoints, such as Zhongwan and Zusanli acupoint, can reduce plasma glucose levels and encourage insulin secretion, even improve insulin resistance. In this study, we want to observe these results on type II diabetic patients who have been diagnosed in five years under a study design of randomized control trial (RCT) to obtain evidence on clinical.
We undertook a randomized, single blind and sham group controlled study to evaluate the effect of EA with a frequency in 15 Hz and fixed intensity (10 mA) on human Zusanli acupoint. A total of 26 newly diagnostic type II diabetic patients are enrolled in this study. They are randomly divided into 2 groups. There are 13 patients in the experimental group (EG) with EA treatment, and the other 13 patients are divided into control group (CG) with sham treatment. The main outcome is the changes of laboratory parameters between before and 30 minutes after the test.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||26 participants|
|Intervention Model:||Factorial Assignment|
|Official Title:||Study of Improving Insulin Sensitivity by Combined Both Electroacupuncture and Drug Therapy|
|Study Start Date :||January 2005|
|Study Completion Date :||December 2005|
- Hypoglycemic activity, plasma insulin level, HOMA index
- Triglyceride, cholesterol, free fatty acid
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00379379
|Graduate Insititude of Integration Chinese And Western Medicine, China Medical University|
|Taichung, Taiwan, 40402|
|Principal Investigator:||Shih-Liang Chang, M.D., Ph.D.||Graduate Institude of Integration Chinese and Western Medicine, China Medical University|